|Title||Estimating direct healthcare costs attributable to laboratory‐confirmed Lyme disease in Ontario, Canada: A population‐based matched cohort study using health administrative data|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Shing E, Wang J, Khoo E, Evans GA, Moore S, Nelder MP, Patel SN, Russell C, Sider D, Sander B|
|Journal||Zoonoses and Public Health|
The objective of this study was to determine healthcare costs attributable to laboratory‐confirmed Lyme disease (LD) from the healthcare payer perspective in Ontario, Canada. A cost‐of‐illness study was conducted for incident LD subjects from 1 January 2006 through 31 December 2013 ascertained from provincial laboratory and reportable disease databases, linked to health administrative data.